Peter Fayers

Peter Fayers

Auto-generated profile, based on publicly available information

Peter Fayers

Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
MHMarianne Jensen Hjermstad
Marianne Jensen Hjermstad
PFPeter M. Fayers
Peter M. Fayers
DHDagny F. Haugen
Dagny F. Haugen
ACAugusto Caraceni
Augusto Caraceni
GHGeoffrey W. Hanks
Geoffrey W. Hanks
SKStein Kaasa
Stein Kaasa

26 February 1999 in British Journal of Cancer
Verified
Journal Article
Open access
ACA Cuschieri
A Cuschieri
SWS Weeden
S Weeden
JFJ Fielding
J Fielding
JBJ Bancewicz
J Bancewicz
JCJ Craven
J Craven
PFP Fayers
P Fayers
Controversy still exists on the optimal surgical resection for potentially curable gastric cancer. Much better long-term survival has been reported in retrospective/non-randomized studies with D2 resections that involve a radical extended regional lymphadenectomy than with the standard D1 resections. In this paper we report the long-term survival of patients entered into a randomized study, with follow-up to death or 3 years in 96% of patients and a median follow-up of 6.5 years. In this prospective trial D1 resection (removal of regional perigastric nodes) was compared with D2 resection (extended lymphadenectomy to include level 1 and 2 regional nodes). Central randomization followed a staging laparotomy. Out of 737 patients with histologically proven gastric adenocarcinoma registered, 337 patients were ineligible by staging laparotomy because of advanced disease and 400 were randomized. The 5-year survival rates were 35% for D1 resection and 33% for D2 resection (difference -2%, 95% CI = -12%-8%). There was no difference in the overall 5-year survival between the two arms (HR = 1.10, 95% CI 0.87-1.39, where HR > 1 implies a survival benefit to D1 surgery). Survival based on death from gastric cancer as the event was similar in the D1 and D2 groups (HR = 1.05, 95% CI 0.79-1.39) as was recurrence-free survival (HR = 1.03, 95% CI 0.82-1.29). In a multivariate analysis, clinical stages II and III, old age, male sex and removal of spleen and pancreas were independently associated with poor survival. These findings indicate that the classical Japanese D2 resection offers no survival advantage over D1 surgery. However, the possibility that D2 resection without pancreatico-splenectomy may be better than standard D1 resection cannot be dismissed by the results of this trial.

1 March 2002 in European Journal of Cancer
Verified
Journal Article
Closed access
PFP Fayers
P Fayers
ABA Bottomley
A Bottomley

2 March 2007
Verified
Book
Open access
PFPeter M. Fayers
Peter M. Fayers
DMDavid Machin
David Machin
Click on the title to browse this book

1 April 1996 in The Lancet
Verified
Journal Article
Closed access
ACA Cuschieri
A Cuschieri
VJV Joypaul
V Joypaul
PFP Fayers
P Fayers
PCP Cook
P Cook
JFJ Fielding
J Fielding
JBJ Bancewicz
J Bancewicz

4 January 2013 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
BRBryce B Reeve
Bryce B Reeve
KWKathleen W. Wyrwich
Kathleen W. Wyrwich
AWAlbert W. Wu
Albert W. Wu
GVGalina Velikova
Galina Velikova
CTCaroline B. Terwee
Caroline B. Terwee
ZBZeeshan Butt
Zeeshan Butt